FDA to assess long-term effects of breast implants

The FDA is holding a meeting over the next two days to discuss the long-term risks of breast implants. There are two types of FDA-approved implants, and about a decade ago, the agency first identified a possible association between the use of implants and a particular type of lymphoma. Women have also reported other side effects, such as fatigue and joint pain after getting implants. The FDA says it will consider post-approval studies as well as issues associated with the use of surgical mesh in breast procedures. The agency will hear from researchers, plastic surgeons, and implant makers, as well as from women who say their implants caused health problems.